SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-053596
Filing Date
2024-05-06
Accepted
2024-05-06 16:30:18
Documents
14
Period of Report
2024-05-01
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tbio-20240501.htm   iXBRL 8-K 78464
2 EX-3.1 tbio-ex3_1.htm EX-3.1 11744
3 EX-99.1 tbio-ex99_1.htm EX-99.1 15218
4 GRAPHIC img44325073_0.jpg GRAPHIC 4733
  Complete submission text file 0000950170-24-053596.txt   247321

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tbio-20240501.xsd EX-101.SCH 27919
18 EXTRACTED XBRL INSTANCE DOCUMENT tbio-20240501_htm.xml XML 5284
Mailing Address 10431 WATERIDGE CIRCLE SUITE 150 SAN DIEGO CA 92121
Business Address 10431 WATERIDGE CIRCLE SUITE 150 SAN DIEGO CA 92121 858-228-4115
Telesis Bio Inc. (Filer) CIK: 0001850079 (see all company filings)

IRS No.: 451216839 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40497 | Film No.: 24917992
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)